Form 4 for IRD Opus Genetics, Inc.
Accepted 2026-04-27 16:28:24 ET · period of report 2026-04-23 · accession 0000905148-26-001866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 16:28 | 2026-04-23 | IRD | SCHACHLE JOSEPH K | COO | S - Sale | $5.22 | -4,697 | 296.1K | -2% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-23 | S | D | 4,697 | $5.22 | 296,084 | D | — | — | (F1) The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person. |